Panel Discussion: Combination vs. Single Agent Therapy: What Does the Future Look Like?

Time: 4:00 pm
day: Day One


• Discussing the advantages and challenges of single agent vs. combination of myeloid therapies with existing
treatment regimens
• Highlighting areas of need in combinations based on mechanistic understanding and medical need
• Considering the challenges of multi-agent therapy with toxicity and demonstrating added benefit of
combination therapy to regulators